Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

TGTXTGTX
Showing 8 of 31 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in TG Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 249,256 shares of TGTX (TG Therapeutics, Inc.), worth $13.7M as of 2026-Q2. The position was increased (+5.8% shares). TGTX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.

Current Value

$13.7M

Current Shares

249,256

Total Value Change

+$6.8M

Total Shares Change

-44,671

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
249,256
+5.8%
$13.7M0.0%$54.94
30
2026-Q1
Decreased
235,477
-1.3%
$7.8M0.0%$28.88
0
2025-Q4
Decreased
238,686
-2.6%
$7.1M0.0%$29.75
0
2025-Q3
Decreased
245,051
-40.1%
$8.9M0.0%$36.83
0
2025-Q2
Increased
409,393
+42.6%
$14.7M0.0%$36.72
38
2025-Q1
Increased
287,059
+5.4%
$11.3M0.0%$39.86
29
2024-Q4
Decreased
272,370
-7.3%
$8.2M0.0%$31.44
0
2024-Q3
Decreased
293,927
-8.7%
$6.9M0.0%$23.83
0

Other major holders of TGTX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used